Name
Inhibrx Biosciences, Inc.
Company Description
Inhibrx is a clinical-stage biopharmaceutical company focused on developing a broad pipeline of novel biologic therapeutic candidates in oncology and orphan diseases. Inhibrx utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary protein engineering platforms. For more information, please visit www.inhibrx.com.
Website
Product Categories (5)
Head and Neck Cancer, Sarcoma/Bone and Soft Tissue Cancers, Developmental Therapeutics, Immunotherapy
First Time Exhibitor
Yes
Phone (If provided, phone will display online and in-print)
858-795-4220
Address
La Jolla, CA
United States
United States
Recognition
